NCT04313452

Brief Summary

Insulin resistance is a common complication of childhood obesity. It is considered to be an important link between adiposity and the risk factor of type 2 diabetes in children. The lifestyle modifications, including a healthy diet, physical activity and weight reduction in obese children and adolescents have been proven effective in type 2 diabetes prevention and management. Although increasing evidence suggests that Mediterranean diet could be associated with decreased risk of metabolic syndrome, diabetes, obesity and atherosclerosis in adults. The importance of this study is to find the effect of Mediterranean diet on insulin resistance among obese children and adolescents aged 10-16 years. Additionally, the results of the present study will help health professionals particularly dietitians in directing children with insulin resistance towards adopting healthy diet and lifestyle.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

February 27, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 18, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

March 18, 2020

Status Verified

March 1, 2020

Enrollment Period

11 months

First QC Date

February 24, 2020

Last Update Submit

March 16, 2020

Conditions

Keywords

Mediterranean Diet

Outcome Measures

Primary Outcomes (2)

  • Mediterranean Diet and insulin Resistance

    Mediterranean Diet change of blood level of Homa IR among Obese Children and Adolescents

    6 month

  • Mediterranean Diet and body weight

    Mediterranean Diet change in body weight in kilogram among Obese Children and Adolescents

    6 month

Secondary Outcomes (1)

  • Mediterranean Diet and lipid profile

    6 month

Study Arms (2)

regular diet

PLACEBO COMPARATOR

50% of energy from carbohydrates, 30% fat and 20% from protein

Other: the effect of Mediterranean diet on insulin sensitivity among obese children and adolescents aged

Mediterranean diet

ACTIVE COMPARATOR

60% of energy from carbohydrates, 25% fat and 15% from protein

Other: the effect of Mediterranean diet on insulin sensitivity among obese children and adolescents aged

Interventions

to find the effect of Mediterranean diet on insulin resistance among obese children and adolescents aged 10-16 years with insulin resistance compared to the regular diet

Also known as: Diet intervention
Mediterranean dietregular diet

Eligibility Criteria

Age10 Years - 16 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age range between 10-16 years.
  • Obese children and adolescents, BMI for age and sex is greater than the +2rd z-score, according to WHO growth chart.
  • Children and adolescents diagnosed with insulin resistance and presence of acanthosis nigricans.
  • Not on medication.

You may not qualify if:

  • Age younger than 10 years or older than 16 years.
  • Overweight children and adolescents or obese (BMI for age and sex is less than +2rd z-score, according to WHO growth chart.
  • Children and adolescents didn't diagnosis of insulin resistance
  • On any medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Jordan

Amman, Jordan

Location

Related Publications (5)

  • Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004 Jan;89(1):108-13. doi: 10.1210/jc.2003-031188.

    PMID: 14715836BACKGROUND
  • Arslanian S, Kim JY, Nasr A, Bacha F, Tfayli H, Lee S, Toledo FGS. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off? Pediatr Diabetes. 2018 Mar;19(2):205-211. doi: 10.1111/pedi.12562. Epub 2017 Jul 20.

  • Bener A. Prevalence of obesity, overweight, and underweight in Qatari adolescents. Food Nutr Bull. 2006 Mar;27(1):39-45. doi: 10.1177/156482650602700106.

  • Bos MB, de Vries JH, Feskens EJ, van Dijk SJ, Hoelen DW, Siebelink E, Heijligenberg R, de Groot LC. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):591-8. doi: 10.1016/j.numecd.2009.05.008. Epub 2009 Aug 18.

  • Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015 Nov 5;7(11):9139-53. doi: 10.3390/nu7115459.

MeSH Terms

Conditions

Pediatric ObesityInsulin Resistance

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Officials

  • Reema F Tayyam, PHD

    University of Jordan

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study sample will consist of 50 participants of obese children and adolescents between 10 and 16 years of age who are diagnosed with insulin resistance clinically. Twenty five of participants (1:1, boys: girls) will follow Mediterranean diet, and 25 of participants (1:1, boys: girls) will follow regular diet. The two groups will be matched for age and gender. The Pediatric Endocrinologist will diagnose the children with insulin resistance clinically according to abdominal obesity and presence of acanthosis nigricans. The children and adolescents will be randomly assigned to one of the groups: Mediterranean diet group or the regular diet group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University of Jordan

Study Record Dates

First Submitted

February 24, 2020

First Posted

March 18, 2020

Study Start

February 27, 2020

Primary Completion

February 1, 2021

Study Completion

February 1, 2021

Last Updated

March 18, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will share

-The study sample will consist of 50 participants of obese children and adolescents between 10 and 16 years of age who are diagnosed with insulin resistance clinically. Twenty five of participants (1:1, boys: girls) will follow Mediterranean diet, and 25 of participants (1:1, boys: girls) will follow regular diet. The two groups will be matched for age and gender. The Pediatric Endocrinologist will diagnose the children with insulin resistance clinically according to abdominal obesity and presence of acanthosis nigricans. The children and adolescents will be randomly assigned to one of the groups: Mediterranean diet group or the regular diet group. The study will be started after getting the Institutional Review Boards (IRB) approval.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
Patients will be followed-up every 2 weeks in the clinic for 6 months
Access Criteria
Obese children and adolescents, BMI for age and sex is greater than the +2rd z-score, according to WHO growth chart, age between 10-16 years. Children and adolescents diagnosed with insulin resistance and presence of acanthosis nigricans and not on medication.

Locations